Deutsche Bank’s Sucampo Pharmaceuticals, Inc. SCMP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q1 | – | Sell |
-448,424
| Closed | -$8.05M | – | 5807 |
|
|
2017
Q4 | $8.05M | Buy |
448,424
+127,459
| +40% | +$1.57M | 0.01% | 1658 |
|
|
2017
Q3 | $3.79M | Buy |
320,965
+230,549
| +255% | +$2.59M | ﹤0.01% | 2083 |
|
|
2017
Q2 | $948K | Sell |
90,416
-181,554
| -67% | -$1.85M | ﹤0.01% | 3069 |
|
|
2017
Q1 | $2.99M | Buy |
271,970
+231,428
| +571% | +$2.69M | ﹤0.01% | 2001 |
|
|
2016
Q4 | $548K | Buy |
40,542
+688
| +2% | +$9.6K | ﹤0.01% | 3123 |
|
|
2016
Q3 | $490K | Buy |
39,854
+8,362
| +27% | +$98.5K | ﹤0.01% | 3204 |
|
|
2016
Q2 | $344K | Buy |
31,492
+23,624
| +300% | +$264K | ﹤0.01% | 3490 |
|
|
2016
Q1 | $85K | Buy |
7,868
+1,701
| +28% | +$21.5K | ﹤0.01% | 4091 |
|
|
2015
Q4 | $106K | Sell |
6,167
-6,844
| -53% | -$123K | ﹤0.01% | 4025 |
|
|
2015
Q3 | $257K | Buy |
13,011
+6,232
| +92% | +$143K | ﹤0.01% | 3684 |
|
|
2015
Q2 | $111K | Sell |
6,779
-29,097
| -81% | -$505K | ﹤0.01% | 4186 |
|
|
2015
Q1 | $557K | Buy |
35,876
+16,251
| +83% | +$252K | ﹤0.01% | 3238 |
|
|
2014
Q4 | $279K | Buy |
19,625
+4,076
| +26% | +$43K | ﹤0.01% | 4105 |
|
|
2014
Q3 | $101K | Buy |
15,549
+7,953
| +105% | +$52.8K | ﹤0.01% | 4499 |
|
|
2014
Q2 | $51K | Sell |
7,596
-4,318
| -36% | -$30.5K | ﹤0.01% | 4921 |
|
|
2014
Q1 | $85K | Buy |
11,914
+5
| +0% | +$43 | ﹤0.01% | 4306 |
|
|
2013
Q4 | $111K | Sell |
11,909
-9,212
| -44% | -$65.7K | ﹤0.01% | 4011 |
|
|
2013
Q3 | $131K | Buy |
21,121
+3,739
| +22% | +$23.4K | ﹤0.01% | 4311 |
|
|
2013
Q2 | $113K | Buy |
+17,382
| New | +$138K | ﹤0.01% | 4162 |
|
Other funds holding SCMP
Deutsche Bank's SCMP Position: Q1 2018 in Review
Deutsche Bank sold out of Sucampo Pharmaceuticals, Inc. (SCMP) in Q1 2018, closing a stake of 448,424 shares — an estimated $8.05M sold.
Deutsche Bank first reported a position in SCMP in Q2 2013 and held it in 19 quarters. The position peaked at $8.05M in Q4 2017. 3 funds tracked by Wall St. Rank hold SCMP as of Q1 2018.
- Deutsche Bank reported no remaining Sucampo Pharmaceuticals, Inc. position as of Q1 2018 after selling out during the quarter.
- Deutsche Bank sold 448,424 Sucampo Pharmaceuticals, Inc. shares in Q1 2018, an estimated $8.05M.
- Deutsche Bank first reported a position in Sucampo Pharmaceuticals, Inc. in Q2 2013 and held it in 19 quarters.
- Deutsche Bank's Sucampo Pharmaceuticals, Inc. position peaked at $8.05M in Q4 2017.
- 3 funds tracked by Wall St. Rank held Sucampo Pharmaceuticals, Inc. as of Q1 2018.
Based on Deutsche Bank's 13F filing for Q1 2018, filed 15 May 2018.